FameLab – a national competition to discover the new faces of UK science launched today in London (Tuesday 8 November 2005). The competition -dubbed the science world’s equivalent of Pop Idol - is the brainchild of the Cheltenham Science Festival and NESTA (the National Endowment for Science, Technology and the Arts) and supported by Pfizer, The Daily Telegraph, Research Councils UK and Channel 4.
Now in its second year, FameLab encourages scientists to inspire and excite public imagination with a vision of science in the 21st century. At regional auditions in Spring 2006 scientists will have just 3 minutes to prove to a panel of expert judges they’ve got what it takes to bring science alive on TV. Ten finalists selected at the heats will go on to compete in the final at the Cheltenham Science Festival. The overall winner of FameLab 2006 will walk away with £2,000, the opportunity to work with a TV producer and pitch their ideas to Channel 4, and a tour of events.
Speaking at the launch Kathy Sykes, Cheltenham Science Festival Director said she was overwhelmed by the success of FameLab at identifying talented communicators. “There is a huge public appetite for science, driven more by curiosity, rather than fear and suspicion and this has been confirmed by the MORI poll commissioned by NESTA and released today. FameLab addresses the public’s desire for clear, concise and accurate information on science both directly through identifying talent, and indirectly by building bridges between the public, the media and science.“
How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung
A gene activated in infant and young brains determines learning capacity in adulthood
13.11.2018 | Universitätsklinikum Hamburg-Eppendorf
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
18.12.2018 | Materials Sciences
18.12.2018 | Physics and Astronomy
18.12.2018 | Physics and Astronomy